Manual Diaphragm Release in Cleaning Laborer
- Conditions
- Respiratory System Abnormalities
- Interventions
- Other: Manual Diaphragm ReleaseOther: control group
- Registration Number
- NCT05802355
- Lead Sponsor
- Maged Basha
- Brief Summary
This study intended to examine the effect of manual diaphragm release on pulmonary function, chest wall mobility, and functional ability in female occupational cleaners with respiratory hazards.
- Detailed Description
Cleaning chores have been linked to exposure to various chemical agents that have the potential to cause harmful effects on both the respiratory system and cardiovascular markers, many cleaning products and disinfectants contain ingredients that can act as airway irritants. One of the physical therapy procedures that is used to manage chest disorders is manual diaphragm release which aims to lengthen the diaphragm musculature whereas encouraging better and more proficient contraction.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 36
- Female occupational cleaners.
- Age between 35 and 45.
- Had work-related respiratory hazards.
- Clinically stable.
- No exacerbation in the previous 6 weeks.
- Working in an occupation with respiratory hazards for at least 2 years.
- Mild to moderate air way obstruction.
- Willingness to participate in this study and provide a consent form.
- Other cardiopulmonary diseases.
- Body mass index > 30 kg/ m2.
- Previous thoracic or abdominal surgery.
- Smokers and users of tobacco in any form (chewing, snuffing or water pipe).
- Systemic conditions (e.g., diabetes mellitus, hypertension).
- Sever airway obstructions.
- Inability to perform the required exercises.
- Inability to attend the scheduled sessions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Manual Diaphragm Release Manual Diaphragm Release received 3sessions/ week for 12 consecutive weeks. control group control group received 3sessions/ week for 12 consecutive weeks.
- Primary Outcome Measures
Name Time Method Forced vital capacity after 12 weeks measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Serum IgE after 12 weeks The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm.
Forced expiratory volume in one second after 12 weeks measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
pulmonary expiratory flow after 12 weeks measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
- Secondary Outcome Measures
Name Time Method Functional performance after 12 weeks Assessed using the 6-minute walk test
Chest wall mobility after 12 weeks measured using tape measurement with maximum inspiration and expiration and the difference between them has been recorded in (cm).
Trial Locations
- Locations (1)
Outpatient Clinic of College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University
🇸🇦Al-Kharj, Riyadh, Saudi Arabia